NSE filing, NSE: VAISHALI. Summary written from the filing by ALFA Finder's alert engine.
Vaishali Pharma Ltd: key numbers
- Share price
- ₹6.81
- Market cap
- ₹91.94 Cr
- Revenue (annual)
- ₹108.8 Cr
- Net profit (annual)
- ₹4.16 Cr
- P/E (TTM)
- 20.8×Sector 46.5×
- Promoter holding
- 31.61%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaishali Pharma Ltd
All →Vaishali Pharma Annual General Meeting
Vaishali Pharma Limited concluded its 19th Annual General Meeting on September 24, 2026, via video conferencing, transacting routine ordinary business matters.
Vaishali Pharma Capital Structure Change
Vaishali Pharma Ltd received listing approval from NSE for 45,37,865 equity shares issued on a preferential basis, subject to depository confirmation.
Vaishali Pharma Annual General Meeting
Vaishali Pharma Limited will hold its 19th Annual General Meeting on September 24, 2026, through video conferencing to transact ordinary business.
Vaishali Pharma Management Change
Vaishali Pharma Limited announced the resignation of Mr. Bhaveshkumar Popatlal Upadhyay from the position of Non-Executive Independent Director, effective August 14, 2026.
Vaishali Pharma Q1 FY27 Results: Net Profit ₹1.5 Cr, Up 15.4% YoY
Vaishali Pharma Ltd reported revenue from operations of ₹22.9 Cr (-3.4% YoY) and net profit of ₹1.5 Cr (+15.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.5 Cr · +15.4% YoY
Vaishali Pharma Board Meeting Date
Vaishali Pharma Limited scheduled a board meeting for August 14, 2026, to approve the standalone and consolidated unaudited financial results for the quarter ended June 2026.
Other preferential issue announcements
All →CCME Global Preferential Issue
CCME Global's Preferential Issue Committee allotted about 15.08 crore equity shares worth Rs 150.84 crore, including shares for cash and for acquiring stakes in CCME UAE and Interlink. Both entities become associate and subsidiary respectively from October 28, 2026.
- Value
- ₹150.8 Cr
Sharp Investments Preferential Issue
Sharp Investment disclosed that its proposed preferential issue is solely to acquire 100% of RLCPL via share swap. The shares carry a nominal Rs.1 face value with no cash consideration.
Avalon Technologies Preferential Issue
Avalon Technologies intimated an EGM on 21 Nov 2026 seeking approval for AoA alterations and a preferential issue of 19,37,808 warrants to Zollner Elektronik AG. The warrants aggregate about ₹425 Crore at ₹2,193.20 each.
- Value
- ₹425.0 Cr
- Execution
- Warrants exercisable for 18 months from allotment
Kuber Udyog Preferential Issue
Kuber Udyog's board approved allotting equity shares and warrants on preferential basis, valued at 276.13 Crore. A share swap acquires 100% of Golden Ikon Fleet Management.
- Value
- ₹276.1 Cr
ACI Infocom Preferential Issue
ACI Infocom allotted 3.2 crore shares and 10 crore warrants to Sanjay & Rupal Mandavia at ₹1.53 each, a ~₹20.20 Crore preferential issue.
- Value
- ₹20.20 Cr
Sharvaya Metals Preferential Issue
Sharvaya Metals corrected its EGM notice on preferential issues of swap shares and warrants, totalling Rs 11.68 Crore. It updates disclosures before the November 6 meeting.
- Value
- ₹11.68 Cr